We are live on ! Find out more
PGM

Parian Global Management Portfolio holdings

AUM $30.8M
1-Year Est. Return 51.25%
This Fund
S&P 500
This Quarter Est. Return
-4.2%
1 Year Est. Return
-51.25%
3 Year Est. Return
+65.19%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$125M
AUM Growth
-$18.8M
Cap. Flow
-$7.78M
Cap. Flow %
-6.24%
Top 10 Hldgs %
68.67%
Holding
51
New
19
Increased
5
Reduced
8
Closed
18

Top Buys

Rank Stock Value
1
VAPO
Vapotherm, Inc. Common Stock
VAPO
+$4.5M
2
TOI icon
The Oncology Institute
TOI
+$4.15M
3
QTRX icon
Quanterix
QTRX
+$3.04M
4
STIM icon
Neuronetics
STIM
+$2.68M
5
BLFS icon
BioLife Solutions
BLFS
+$2.36M

Top Sells

Rank Stock Value
1
SERA icon
Sera Prognostics
SERA
+$7.35M
2
CMAX
CareMax, Inc. Class A Common Stock
CMAX
+$5.74M
3
USIO icon
Usio Inc
USIO
+$4.92M
4
GDRX icon
GoodRx Holdings
GDRX
+$4.7M
5
OPFI icon
OppFi
OPFI
+$3.06M

Sector Composition

Rank Sector Weight
1 Healthcare 86.76%
2 Technology 1.93%
3 Communication Services 0%
4 Consumer Staples 0%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSTL icon
26
Castle Biosciences
CSTL
$855M
$1.26M 1.02%
+29,498
New +$1.54M
ISO
27
DELISTED
IsoPlexis Corporation Common Stock
ISO
$1.12M 0.9%
+122,330
New +$1.36M
STIM icon
28
CALL
Neuronetics
STIM
$138M
$892K 0.72%
200,000
– –
QDEL icon
29
QuidelOrtho
QDEL
$1.14B
$810K 0.65%
+6,000
New +$835K
TKNO icon
30
Alpha Teknova
TKNO
$268M
$780K 0.63%
+38,069
New +$844K
XRAY icon
31
CALL
Dentsply Sirona
XRAY
$2.68B
$418K 0.34%
+7,500
New +$412K
RNLX
32
CALL
DELISTED
Renalytix plc American Depositary Shares
RNLX
$239K 0.19%
+15,000
New +$300K
RNLX
33
PUT
DELISTED
Renalytix plc American Depositary Shares
RNLX
$89K 0.07%
+5,600
New +$112K
ACTG icon
34
Acacia Research
ACTG
$428M
– –
-12,602
Closed -$86K
CLPT icon
35
CALL
ClearPoint Neuro
CLPT
$448M
– –
-15,000
Closed -$317K
CLPT icon
36
ClearPoint Neuro
CLPT
$448M
– –
-153,950
Closed -$2.73M
EB
37
DELISTED
Eventbrite
EB
– –
-135,617
Closed -$2.56M
GDRX icon
38
GoodRx Holdings
GDRX
$1.04B
– –
-114,457
Closed -$4.7M
HAPN
39
Happen Inc
HAPN
$2.21B
– –
-62,727
Closed -$1.77M
LYRA
40
DELISTED
LYRA THERAPEUTICS INC
LYRA
– –
-2,426
Closed -$1.11M
NYXH
41
Nyxoah
NYXH
$140M
– –
-56,334
Closed -$1.59M
OPFI icon
42
OppFi
OPFI
$800M
– –
-389,315
Closed -$3.06M
OSCR icon
43
Oscar Health
OSCR
$9.41B
– –
-166,034
Closed -$2.89M
PAVM icon
44
PAVmed
PAVM
$35.4M
– –
-630
Closed -$2.42M
RBOT
45
CALL
DELISTED
Vicarious Surgical
RBOT
– –
-833
Closed -$249K
RBOT
46
DELISTED
Vicarious Surgical
RBOT
– –
-5,174
Closed -$2.32M
SKIN icon
47
SkinHealth Systems
SKIN
$88.8M
– –
-65,300
Closed -$1.7M
EAR
48
DELISTED
Eargo, Inc. Common Stock
EAR
– –
-5,579
Closed -$751K
CMAX
49
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
– –
-19,801
Closed -$5.74M
BHVN
50
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-10,000
Closed -$684K
1
2
3

Similar funds

VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
ACM
Afton Capital Management Charlotte, North Carolina $30.6M AUM 56.8% 1-Year Est. Return
LUGPSI
Lightspeed Ultimate General Partner Select III Menlo Park, California $31M AUM 76.89% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
KL
Kokino LLC Stamford, Connecticut $28M AUM 16.9% 1-Year Est. Return

Parian Global Management's Q4 2021 Portfolio in Review

As of Q4 2021, Parian Global Management held 51 positions worth $125M, down 13% from $143M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Parian Global Management withdrew a net $7.78M in Q4 2021, closing 18 positions and reducing 8 holdings. Its most notable exit was CareMax, Inc. Class A Common Stock, an estimated $5.74M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 85% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Parian Global Management opened a new position in The Oncology Institute worth $4.55M.

  • Parian Global Management's largest Q4 2021 buy was The Oncology Institute: 466,676 shares worth $4.55M.
  • Parian Global Management added most to Vapotherm, Inc. Common Stock in Q4 2021, an estimated $4.5M increase.
  • Parian Global Management's biggest Q4 2021 reduction was Sera Prognostics, cutting an estimated $7.35M.
  • Parian Global Management fully exited CareMax, Inc. Class A Common Stock in Q4 2021, selling an estimated $5.74M.
  • Parian Global Management's ten largest holdings make up 69% of its $125M portfolio in Q4 2021.
  • Parian Global Management opened 19 new positions and closed 18 in Q4 2021.
  • Parian Global Management's portfolio value fell 13% quarter-over-quarter to $125M.

Based on Parian Global Management's 13F filing for Q4 2021, filed 14 Feb 2022.